共 136 条
[1]
Huggins C(1941)Studies of prostatic cancer: I. Effect of castration, estrogen and androgen injections on serum phosphatase in metastatic carcinoma of the prostate Cancer Res 1 293-297
[2]
Hodges C(2004)Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression Urology 64 1182-1186
[3]
Higano C(1997)Influence of urological morbidity on quality of life in patients with prostate cancer Eur Urol 31 3-8
[4]
Shields A(1995)Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report Urology 45 839-844
[5]
Wood N(2003)Intermittent androgen suppression in patients with prostate cancer BJU Int 91 18-22
[6]
Brown J(1993)Effects of intermittent androgen suppression on androgen-dependent tumours. Apoptosis and serum prostate-specific antigen Cancer 71 2782-2790
[7]
Tangen C(1996)Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model J Steroid Biochem Mol Biol 58 139-146
[8]
Fossa SD(1982)Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649-655
[9]
Woehre H(1975)Grading of prostatic carcinoma Cancer Chemother Rep 59 111-117
[10]
Kurth KH(2004)Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study Urology 64 341-345